Digital Media Center
Bryant-Denny Stadium, Gate 61
920 Paul Bryant Drive
Tuscaloosa, AL 35487-0370
(800) 654-4262

© 2024 Alabama Public Radio
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

What's Ahead For The COVID-19 Vaccine Rollout?

Harvard T.H. Chan School of Public Health

As the rollout of COVID-19 vaccines unfolds in the U.S., numerous questions around distribution, supply, hesitancy and efficacy persist. Experts from Harvard and the CDC will tackle these questions.

Watch an expert panel discussion on the effort to deploy against COVID-19 on Friday, Jan. 22, to be live-streamed here at 12 p.m. ET, as part of The Forum at the Harvard T.H. Chan School of Public Health.

You can email your questions to theforum@hsph.harvard.edu.

Scott Hensley, an editor on NPR's Science Desk, will moderate the discussion with:

Nancy Messonnier, director of the National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention

Barry Bloom, the Joan and Jack Jacobson research professor of public health and former dean of the Harvard Chan School

Marc Lipsitch, professor of epidemiology and director of the Center for Communicable Disease Dynamics at the Harvard Chan School, and

Sandra Nelson, associate physician, Division of Infectious Diseases, Massachusetts General Hospital.

This event is part of the Dr. Lawrence H. and Roberta Cohn Forum series.

You can email your questions to theforum@hsph.harvard.edu.

Copyright 2021 NPR. To see more, visit https://www.npr.org.

Scott Hensley edits stories about health, biomedical research and pharmaceuticals for NPR's Science desk. During the COVID-19 pandemic, he has led the desk's reporting on the development of vaccines against the coronavirus.
News from Alabama Public Radio is a public service in association with the University of Alabama. We depend on your help to keep our programming on the air and online. Please consider supporting the news you rely on with a donation today. Every contribution, no matter the size, propels our vital coverage. Thank you.